Comparison Lineage Cell Therapeutics (LCTX) with Competitors
Lineage Cell Therapeutics (LCTX) industry is Biotechnology.
Operating Margin
LCTX-440.20%
Industry-2073.25%
Upside+1633.05%
Free Cash Flow Yield
LCTX-6.92%
Industry-1.94%
Upside-4.98%
P/E
LCTX-4.70
Industry-18.88
Upside+1417.47%
Forward P/E
LCTX30.67
Industry15.31
Upside+100.32%
P/S
LCTX22.43
Industry9.28
Upside+141.65%
P/B
LCTX6.15
Industry4.70
Upside+30.92%